A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.

被引：0
|
作者：
Landen, Charles N.
Buckanovich, Ronald J.
Sill, Michael
Mannel, Robert S.
Walker, Joan L.
Disilvestro, Paul
Mathews, Cara Amanda
Mutch, David Gardner
Hernandez, Marcia
Martin, Lainie P.
Bishop, Erin
Gill, Sarah
Gordinier, Mary E.
Burger, Robert Allen
Aghajanian, Carol
Liu, Joyce F.
Moore, Kathleen N.
Bookman, Michael A.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[3] Gynecol Oncol Grp Stat & Data Ctr, Buffalo, NY USA
[4] Stephenson Canc Ctr, Oklahoma City, OK USA
[5] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA
[6] Women Infants Hosp, Providence, RI USA
[7] Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Program Womens Oncol, Providence, RI USA
[8] Washington Univ St Louis, Sch Med, St Louis, MO USA
[9] Mercy Hosp Springfield, Springfield, MO USA
[10] Univ Pennsylvania, Abramson Canc Ctr, Philadelphia, PA USA
[11] Froedtert & Med Coll Wisconsin, Milwaukee, WI USA
[12] Nancy N & JC Lewis Canc & Res Pavil, Savannah, GA USA
[13] Louisville Oncol, Louisville, KY USA
[14] Univ Pennsylvania, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA USA
[15] Mem Sloan Kettering Canc Ctr, New York, NY USA
[16] Dana Farber Canc Inst, Boston, MA USA
[17] Univ Oklahoma Hlth Sci Ctr, Div Obstet & Gynecol, Dept Gynecol Oncol, Stephenson Canc Ctr, Oklahoma City, OK USA
[18] Univ Arizona, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5501
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
    Donald A. Richards
    David Loesch
    Svetislava J. Vukelja
    Hillary Wu
    William J. Hyman
    Jeffery Nieves
    Yunfei Wang
    Simin Hu
    Oluwatoyin O. Shonukan
    Datchen F. Tai
    Investigational New Drugs, 2011, 29 : 963 - 970
  • [32] Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
    Richards, Donald A.
    Loesch, David
    Vukelja, Svetislava J.
    Wu, Hillary
    Hyman, William J.
    Nieves, Jeffery
    Wang, Yunfei
    Hu, Simin
    Shonukan, Oluwatoyin O.
    Tai, Datchen F.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 963 - 970
  • [33] Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer
    Taylor, Sarah E.
    Chu, Tianjiao
    Elvin, Julia A.
    Edwards, Robert P.
    Zorn, Kristin K.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (01) : 32 - 37
  • [34] PATTERNS OF CARE FOR PATIENTS WITH ADVANCED OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER: A RETROSPECTIVE AUDIT
    Lin, E.
    Lo, C.
    Richardson, G.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 54 - 54
  • [35] THROMBOEMBOLIC EVENTS POST CYTOREDUCTIVE SURGERY IN PATIENTS WITH OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    Atallah, D.
    Farraj, K. Abi
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A500 - A500
  • [36] A multicentre phase II study of AZD1775 plus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Moore, K. N.
    Cadoo, K. A.
    Chambers, S.
    Ghamande, S.
    Konecny, G.
    Oza, A. M.
    Chen, L-M.
    Konstantinopoulos, P. A.
    Lea, J.
    Spitz, D.
    Uyar, D.
    Mugundu, G.
    Laing, N.
    Strickland, D. K.
    Jones, S.
    Burris, H.
    Spigel, D. R.
    Hamilton, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] THROMBOEMBOLIC EVENTS POST CYTOREDUCTIVE SURGERY IN PATIENTS WITH OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    Atallah, D.
    Farraj, K. Abi
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A47 - A47
  • [38] Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer
    Atallah, D.
    Moubarak, M.
    Farraj, K. Abi
    El Kassis, N.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 148 - 148
  • [39] A phase 3 study of trabectedin (T) plus pegylated liposomal doxorubicin (PLD) versus PLD for treatment of advanced relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer.
    Coleman, Robert L.
    Monk, Bradley J.
    del Carmen, Marcela G.
    Knoblauch, Roland Elmer
    Parekh, Taal V.
    Dawkins, Fitzroy W.
    Maul, Raymond Scott
    Park, Youn Choi
    Herzog, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial
    Park, Soo Jin
    Shim, Seung-Hyuk
    Ji, Yong-Il
    Kwon, Sang-Hoon
    Lee, Eun Ji
    Lee, Maria
    Chang, Suk Joon
    Park, Samina
    Kim, Sang Youn
    Lee, Sung Jong
    Kim, Jae-Weon
    Roh, Ju-Won
    Lee, San Hui
    Song, Taejong
    Kim, Hee Seung
    BMC CANCER, 2020, 20 (01)
12345